["Symptoms and quality of life following hospitalisation for COVID-19 (post COVID-19 syndrome/long COVID) in the ISARIC WHO clinical characterisation protocol UK: preliminary results", "A common TMPRSS2 variant has a protective effect against severe COVID-19", "Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol", "Establishment of the WHO International Standard and Reference Panel for anti-SARS-CoV-2 antibody on behalf of the ISARIC4C Investigators", "Obesity, ethnicity, and risk of critical care, mechanical ventilation, and mortality in patients admitted to hospital with COVID\u201019: analysis of the ISARIC CCP\u2010UK cohort", "Procalcitonin is not a reliable biomarker of bacterial coinfection in people with coronavirus disease 2019 undergoing microbiological investigation at the time of hospital \u2026", "Identification and quantification of SARS-CoV-2 leader subgenomic mRNA gene junctions in nasopharyngeal samples shows phasic transcription in animal models of COVID-19 and \u2026", "UK Obstetric Surveillance System, COVID-19 Clinical Information Network: UKOSS", "Characteristics and outcomes of an international cohort of 400,000 hospitalised patients with Covid-19", "COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study", "Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility", "Evaluation of S/F94 as a proxy for COVID-19 severity", "Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the \u2026", "ISARIC4C investigators, 2021. Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical \u2026", "Evaluation of the effectiveness of remdesivir in severe COVID-19 using observational data from a prospective national cohort study", "Robust, reproducible clinical patterns in hospitalised patients with COVID-19", "Establishment of 1st WHO International Standard for anti-MERS-CoV antibody", "The UK hibernated pandemic influenza research portfolio: triggered for COVID-19", "SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures", "Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study", "Ethnicity and outcomes from COVID-19: the ISARIC CCP-UK prospective observational cohort study of hospitalised patients", "Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020", "Admission blood glucose level and its association with cardiovascular and renal complications in patients hospitalized with COVID-19", "ISARIC COVID-19 Clinical Data Report: 4 October 2020", "A common TMPRSS2 variant protects against severe COVID-19", "Medical vulnerability of individuals with Down syndrome to severe COVID-19\u2013data from the Trisomy 21 Research Society and the UK ISARIC4C survey", "Clonal hematopoiesis is not significantly associated with Covid-19 disease severity", "COVID\u201019 and older adults with Down syndrome: Presentation, complications and risk for mortality", "Mapping the human genetic architecture of COVID-19", "SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses", "Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19", "Cancer datasets and the SARS-CoV-2 pandemic: establishing principles for collaboration", "Elevated antiviral, myeloid and endothelial inflammatory markers in severe COVID-19", "HIV associated with worse outcomes from COVID-19 in UK ISARIC and OpenSAFELY databases", "Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.", "Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational \u2026", "Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity", "Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol", "International severe acute respiratory and emerging infections consortium coronavirus clinical characterization consortium (ISARIC4C) investigators. Procalcitonin is not a \u2026", "Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical \u2026", "A haemagglutination test for rapid detection of antibodies to SARS-CoV-2", "Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study", "Circulating histones play a central role in COVID-19-associated coagulopathy and mortality", "Fewer COVID\u201019 Neurological Complications with Dexamethasone and Remdesivir", "Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK", "Neurological Presentations and In-Hospital Complications of COVID-19 in Adults and Children: A Large Prospective Multicentre Observational Study from the International Severe \u2026", "Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium \u2026", "A prenylated dsRNA sensor protects against severe COVID-19", "A Prenylated dsRNA Sensor Protects Against Severe COVID-19 and is Absent in Horseshoe Bats", "Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study", "The value of open-source clinical science in pandemic response: lessons from ISARIC", "SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study", "Association of country income level with the characteristics and outcomes of critically ill patients hospitalized with acute kidney injury and COVID-19", "Recovery from Covid-19 critical illness: a secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial (preprint)", "Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19", "ISARIC coronavirus clinical characterisation consortium", "ISARIC clinical data report 20 November 2020", "COVID-19 symptoms at hospital admission vary with age and sex: ISARIC multinational study", "GWAS and meta-analysis identifies multiple new genetic mechanisms underlying severe Covid-19", "Global outbreak research: harmony not hegemony", "Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England", "Towards nationally curated data archives for clinical radiology image analysis at scale: Learnings from national data collection in response to a pandemic", "A retrospective cluster analysis of COVID-19 cases by county (preprint)", "The impact of viral mutations on recognition by SARS-CoV-2 specific T cells", "ISARIC4C investigators, Khunti K. Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID-19: Analysis \u2026", "ISARIC-COVID-19 dataset: A prospective, standardized, global dataset of patients hospitalized with COVID-19", "Erratum: Department of Error (The Lancet (2021) 398 (10296)(223\u2013237),(S0140673621007996),(10.1016/S0140-6736 (21) 00799-6))", "Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study", "1H NMR Signals from Urine Excreted Protein Are a Source of Bias in Probabilistic Quotient Normalization", "Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low-and middle-income \u2026", "Understanding inequalities in COVID-19 outcomes following hospital admission for people with intellectual disability compared to the general population: a matched cohort study \u2026", "Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol", "Amplicon-based detection and sequencing of SARS-CoV-2 in nasopharyngeal swabs from patients with COVID-19 and identification of deletions in the viral genome that encode \u2026", "A gene locus that controls expression of ACE2 in virus infection", "ISARIC4C: Multicentre cohort study on symptoms and quality of life following hospitalisation for COVID-19-preliminary results, 25 February 2021", "Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: Antibody dynamics and linkage to severity of COVID-19 in hospital inpatients", "Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave", "Symptoms at presentation for patients admitted to hospital with Covid-19: results from the ISARIC prospective multinational observational study", "Plasma steroid profiles in patients hospitalised with COVID-19-an ISARIC/WHO CCP-UK cohort study", "ISARIC COVID-19 Clinical Data Report issued: 15 December 2021", "Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19", "Hospitalised Vaccinated Patients during the Second Wave", "Investigadores de ISARIC4C. Caracter\u00edsticas de 20133 pacientes del Reino Unido hospitalizados con COVID-19 utilizando el Protocolo de Caracterizaci\u00f3n Cl\u00ednica de la OMS de \u2026", "Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre \u2026", "Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score", "Females in hospital with SARS-CoV-2 infection, the association with pregnancy and pregnancy outcomes: a UKOSS/ISARIC/CO-CIN investigation", "the COVID-19 Genomics UK (COG-UK) consortium, The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity", "ISARIC Clinical Data Report 3 September 2020", "COVID-19 Clinical Information Network (CO-CIN). Females in hospital with SARS-CoV-2 infection, the association with pregnancy and pregnancy outcomes: A UKOSS", "Hospitalised vaccinated patients during the second wave, update April \u201821", "Enrichment of Sars-Cov-2 and Seasonal Coronavirus Sequence from Nasopharyngeal Swabs Whilst Maintaining the Background Context of the Microbiome", "HLA-E\u2013restricted SARS-CoV-2\u2013specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation", "ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19", "What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol", "Further antibody escape by Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum", "Neutralising antibodies to SARS coronavirus 2 in Scottish blood donors-a pilot study of the value of serology to determine population exposure", "Outcomes of COVID-19 related hospitalisation among people with HIV in the ISARIC WHO Clinical Characterisation Protocol UK Protocol: prospective observational study", "Cycle threshold values are inversely associated with poorer outcomes in hospitalized patients with COVID-19: a prospective, observational cohort study conducted at a UK \u2026", "the collaborative study participants. Establishment of the WHO International Standard and Reference Panel for anti-SARS-CoV-2 antibody on behalf of the ISARIC4C Investigators", "Adeno-associated virus 2 infection in children with non-A\u2013E hepatitis", "ISARIC clinical data report issued: 14 July 2021", "Symptom\u2010based case definitions for COVID\u201019: Time and geographical variations for detection at hospital admission among 260,000 patients", "Fitting models to the COVID-19 outbreak and estimating R", "Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number", "Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study", "Understanding severe coronavirus disease in humans from the analysis of clinical samples with RNA sequencing", "Clinical Characterisation Protocol (CCP): UK version, 2020", "SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination", "Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study", "on behalf of the ISARIC4C investigators. Elevated antiviral, myeloid and endothelial inflammatory markers in severe COVID-19", "Genetic mechanisms of critical illness in COVID-19", "Large scale phenotyping of long COVID inflammation reveals mechanistic subtypes of disease", "Vaccination after recovery from COVID-19 affects nasal antibody levels", "Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study", "Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity", "Development and validation of the 4C Deterioration model for adults hospitalised with COVID-19", "ISARIC4C investigators", "A multi-country analysis of COVID-19 hospitalizations by vaccination status", "Coinfection with influenza viruses is associated with worse outcomes in severe Covid-19", "ISARIC COVID-19 Clinical Data Report: 13 July 2020", "Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study", "An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients", "Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. medRxiv, 2021 \u2026", "Nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.", "The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity", "Prospective data of first 1,797 hospitalised patients with cancer and COVID-19 derived from the COVID-19 Clinical Information Network and international Severe Acute Respiratory \u2026", "The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020", "Clinical characterisation protocol (CCP): ISARIC, 2012", "ISARIC Clinical Data Report 10 February 2021", "Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study", "Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum", "Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera", "Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study", "Potent cross-reactive antibodies following Omicron breakthrough in vaccinees", "Sequence analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the in vitro growth \u2026", "Impact of dexamethasone and remdesivir on neurological complications during COVID-19", "Negative regulation of ACE2 by interferons in vivo and its genetic control.", "Analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the growth properties of variants \u2026", "Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19", "Changes in UK hospital mortality in the first wave of COVID-19: the ISARIC who clinical characterisation protocol prospective multicentre observational cohort study", "Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge", "ISARIC4C investigators.(2020)", "CMMID C-19 Working Group with MRC Imperial College C-19 Response Team, ISARIC4C Investigators.(2020, December 4).\u201cShort-term forecasts to inform the response to the Covid-19 \u2026", "Robust, reproducible clinical patterns in hospitalised patients with COVID-19 (preprint)", "Rapid selection of P323L in the SARS-CoV-2 polymerase (NSP12) in humans and non-human primate models and confers a large plaque phenotype", "An overview of the National COVID-19 Chest Imaging Database: data quality and cohort analysis", "Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study", "International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC)", "Hospital admission for symptomatic COVID\u201019 and impact of vaccination: analysis of linked data from the Coronavirus Clinical Information Network and the National Immunisation \u2026", "Estimating distribution of length of stay in a multi-state model conditional on the pathway, with an application to patients hospitalised with Covid-19", "Recovery from Covid-19 critical illness: A secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial", "Imperial College COVID-19 Response Team, ISARIC4C Investigators", "Hospital-acquired SARS-CoV-2 infection in UK", "ISARIC (International Severe Acute Respiratory and Emerging Infections Consortium)", "ISARIC Working Group 3, ISARIC Council. Open source clinical science for emerging infections", "Oxford Immunology Network Covid-19 Response T cell Consortium; ISARIC4C Investigators, Cornall RJ, Conlon CP, Klenerman P, Screaton GR, Mongkolsapaya J, McMichael A, Knight JC \u2026", "COVID-19 pneumothorax in the UK: a prospective observational study using the ISARIC WHO clinical characterisation protocol", "International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) COVID-19 Report: 06 May 2020", "Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses", "ISARIC COVID-19 clinical data report: 8 June 2020", "Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study", "Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration", "Covid-19 Case Report Form Oxford", "Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID\u201019", "DIAMONDS consortium, ISARIC4C Investigators, Robertson DL, Filipe A, Willett B, Breuer J, Semple MG, Turner D, Baillie JK, Thomson EC", "Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults", "The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection", "Comparison of children and young people admitted with SARS-CoV-2 across the UK in the first and second pandemic waves: prospective multicentre observational cohort study", "SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses", "Importance of patient bed pathways and length of stay differences in predicting COVID-19 bed occupancy in England", "Hospitalised vaccinated patients during the second wave, 11 March 2021. Scientific Advisory Group for Emergencies 2021", "Neurological manifestations of COVID-19 in adults and children", "Prevention of neurological complications during COVID-19: protocol for a retrospective analysis of the ISARIC4C national cohort", "Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves", "Short-term forecasts to inform the response to the Covid-19 epidemic in the UK", "Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study", "Comparative evaluation of ten lateral flow immunoassays to detect SARS-CoV-2 antibodies", "Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study", "Protocol for the development and evaluation of a tool for predicting risk of short-term adverse outcomes due to COVID-19 in the general UK population", "OPTIC consortium, ISARIC4C consortium, NG Paterson, MA Williams, DR Hall, J. Mongkolsapaya, EE Fry, W. Dejnirattisai, J. Ren, DI Stuart, GR Screaton, Potent cross-reactive \u2026", "In vivo negative regulation of SARS-CoV-2 receptor, ACE2, by interferons and its genetic control", "Histological evidence of pulmonary microthrombosis and vasculitis in life-threatening respiratory virus diseases", "Evaluation of the effectiveness of remdesivir in treating severe COVID-19 using data from the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, national cohort study", "Reply to Russo et al", "Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study", "An international survey on the impact of COVID-19 in individuals with Down syndrome", "Coinfection with influenza viruses is associated with worse outcomes in severe Covid-19, an ISARIC4C/CO-CIN Report", "Obesity, chronic disease, age, and in-hospital mortality in patients with covid-19: analysis of ISARIC clinical characterisation protocol UK cohort", "COVID-19 clinical research resources", "A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process", "Validation of extracorporeal membrane oxygenation mortality prediction and severity of illness scores in an international COVID\u201019 cohort"]